Biotechnology - Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of...
5/5/2008 9:00:00 PM
[NEWS]Preclinical findings of amylin/leptin synergy and translational Phase 2A clinical results published online today in Proceedings of the National Academy of Sciences of the United States of America SAN DIEGO, May 5 /PRNewswire-FirstCall/ — Amylin Pharmaceuticals, Inc.(Nasdaq: AMLN) today announced the initiation of a Phase 2B clinical studyevaluating various dosing combinations of pramlintide, an analog of thenatural hormone amylin, and recombinant human leptin (r-metHuLeptin;…
...
full article